mara rada's Linkedin Analytics

Innovation Strategist, Advertiser, and Biosciences Commercialization Executive at Loon Inc. Harnassing Cognitive Ensemble AI Systems™ and patient-driven insights for AI Market Access Forecasting and Evidence Synthesis to streamline the commercialization of innovative medicines and drastically reduce the time-to-patient of life-saving medications. Loon™ forecasts market access reimbursement committee decisions and conditions, offering insights to optimize submissions and value dossiers. We de-risk the commercialization and market access of drugs and medical devices to accelerate time-to-patient, at the same time helping medical innovators make their products available to patients faster and get reimbursed by payers without delay. Loon fast-tracks evidence synthesis research (systematic literature reviews and indirect treatment comparisons) to accelerate market access and help improve patient access to novel therapeutics. The company’s patent-pending technology and agentic AI services are an industry game-changer and a win-win for all healthcare stakeholders: patients, manufacturers, regulators, and payers. With over two decades of untamed thinking and experience in positioning, naming, and developing brand assets for Fortune 50 and Fortune 500 companies and iconic brands like Pfizer, La Roche, Glaxo, Dove, Gillette, or Heineken, I've transitioned to co-founding Loon, where I serve as the Chief of Operations and Strategy. Having worked with global market leaders like P&G, Kraft Foods, and Unilever and being a Global Startup Mentor in tier-1 accelerators like Techstars and Founder Institute, I bring a wealth of strategic insight to revolutionize clinical research and healthcare technologies. I welcome connections from like-minded professionals passionate about leveraging technology to redefine healthcare. Feel free to reach out and discuss collaborative possibilities focused on uncovering patient-led clinical insights and streamlining clinical evidence synthesis and analytics.